Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000544·Adaptimmune Therapeutics PLC
Schedule 13G ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Ordinary Shares · CUSIP: 00653A107
Event date: 2025-08-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 66,000,000.00 · Class: 4.2%
- Oleg Nodelman
Shares: 66,000,000.00 · Class: 4.2%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 63,184,650.00 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000544
- Form type
- SCHEDULE 13G/A
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- Aug 19, 2025
- Reporting period
- Aug 15, 2025
- Description
- Schedule 13G beneficial ownership